1. Clinical Overview
Testosterone is the primary endogenous androgen, a steroid hormone synthesized from cholesterol in the Leydig cells of the testes (95%), and to a lesser extent in the adrenal cortex and ovaries. In the Indian pharmaceutical market, a 40mg dose is typically available as a transdermal gel or as a component of a compounded injection, primarily used for Testosterone Replacement Therapy (TRT) in adult males with hypogonadism. It exerts profound anabolic and androgenic effects by binding to and activating the androgen receptor, influencing gene transcription in target tissues.
| Onset | Duration | Bioavailability |
|---|---|---|
| Transdermal gel: Initial physiological effects may be noticed within 1-3 days; steady-state serum levels achieved in approximately 2-3 days. Intramuscular injection (as part of a blend): Effects begin within 24-72 hours. | Transdermal gel: Requires daily application to maintain stable serum levels. Intramuscular injection (e.g., as part of Sustanon 250 blend): Effects can last 2-4 weeks depending on the ester. | Oral unmodified testosterone is >90% first-pass metabolism, hence not used. Transdermal gel: Approximately 10-14% absorption through skin. Intramuscular esters: Near 100%. |
2. Mechanism of Action
Testosterone enters target cells via passive diffusion. In androgen-responsive tissues (like prostate, skin), it is converted by 5α-reductase to the more potent metabolite dihydrotestosterone (DHT). Both testosterone and DHT bind to the intracellular androgen receptor (AR) in the cytoplasm, causing dissociation of heat shock proteins, dimerization, and translocation to the nucleus. The hormone-receptor complex binds to specific DNA sequences (Androgen Response Elements - AREs), regulating the transcription of androgen-dependent genes, leading to protein synthesis and cellular effects.
3. Indications & Uses
- Male Hypogonadism (Primary and Hypogonadotropic)
- Delayed Puberty in Males (with specific protocols)
4. Dosage & Administration
Adult Dosage: For TRT in Hypogonadism: Transdermal gel (1% or 1.62%): 40-100mg applied once daily to clean, dry skin on shoulders, upper arms, or abdomen. Dose is titrated based on serum testosterone levels measured 2-8 hours after application. As part of IM blend (e.g., Sustanon 250 contains 40mg propionate): 250mg IM every 2-4 weeks, but the 40mg component is short-acting.
Administration: Transdermal Gel: Apply to clean, dry, intact skin on shoulders, upper arms, or abdomen. Wash hands thoroughly after application. Allow site to dry before dressing. Do not apply to genitals. Cover application site if close skin-to-skin contact with another person (especially women/children) is anticipated. IM Injection: Deep intramuscular into gluteal muscle. Rotate sites. Use aseptic technique.
5. Side Effects
Common side effects may include:
- Acne, oily skin
- Application site reactions (for gel): itching, blistering
- Increased hematocrit/hemoglobin
- Headache
- Mood swings, increased aggression
- Gynecomastia (due to aromatization)
- Fluid retention, edema
- Alopecia (male pattern baldness in predisposed individuals)
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Warfarin | Testosterone may potentiate anticoagulant effect by increasing clotting factor synthesis? Actually, it can both increase and decrease factors; more importantly, it can increase hematocrit, affecting blood viscosity. Monitor INR closely. | Major |
| Corticosteroids (e.g., Prednisolone) | Increased risk of fluid retention and edema. | Moderate |
| Insulin, Oral Hypoglycemics | Testosterone may decrease blood glucose; may alter insulin requirements. Monitor blood glucose. | Moderate |
| Cyclosporine, Tacrolimus | Testosterone may inhibit CYP3A4, potentially increasing levels of these drugs and risk of toxicity. | Moderate |
| Prostate cancer drugs (e.g., GnRH agonists) | Antagonistic effect. Contraindicated. | Major |
| ACTH or Corticosteroids | Enhanced edema. | Moderate |
7. Patient Counselling
- DO apply transdermal gel as directed, at the same time each day.
- DO wash hands thoroughly with soap and water after application.
- DO cover the application site with clothing to prevent transfer to others.
- DO attend all scheduled follow-up appointments for blood tests (Testosterone, PSA, Hematocrit, Lipids).
- DON'T apply gel to broken or irritated skin, or to genitals.
- DON'T allow women, children, or pets to come into contact with the unwashed or unclothed application site.
- DON'T donate blood while on therapy (due to risk of polycythemia and potential transfer to transfusion recipient).
- DON'T share your medication; it is a controlled substance.
8. Toxicology & Storage
Overdose: Symptoms are an extension of side effects: Severe nausea, vomiting, headache, anxiety, aggressive behavior ('roid rage'), priapism, significant polycythemia (leading to thrombotic risk), severe fluid retention (leading to CHF), jaundice (hepatotoxicity).
Storage: Store at room temperature (15-30°C). Protect from light and moisture. Keep transdermal gel sachets/tubes in their original container. Keep out of reach of children and pets. Do not freeze. For used/unused sachets, dispose of carefully in household trash, ensuring they are not accessible to children or animals.